Abstract:Characterizing complex biofluids using surface-enhanced Raman spectroscopy (SERS) coupled with machine learning (ML) has been proposed as a powerful tool for point-of-care detection of clinical disease. ML is well-suited to categorizing otherwise uninterpretable, patient-derived SERS spectra that contain a multitude of low concentration, disease-specific molecular biomarkers among a dense spectral background of biological molecules. However, ML can generate false, non-generalizable models when data sets used for model training are inadequate. It is thus critical to determine how different SERS experimental methodologies and workflow parameters can potentially impact ML disease classification of clinical samples. In this study, a label-free, broadband, Ag nanoparticle-based SERS platform was coupled with ML to assess simulated clinical samples for cardiovascular disease (CVD), containing randomized combinations of five key CVD biomarkers at clinically relevant concentrations in serum. Raman spectra obtained at 532, 633, and 785 nm from up to 300 unique samples were classified into physiological and pathological categories using two standard ML models. Label-free SERS and ML could correctly classify randomized CVD samples with high accuracies of up to 90.0% at 532 nm using as few as 200 training samples. Spectra obtained at 532 nm produced the highest accuracies with no significant increase achieved using multiwavelength SERS. Sample preparation and measurement methodologies (e.g., different SERS substrate lots, sample volumes, sample sizes, and known variations in randomization and experimental handling) were shown to strongly influence the ML classification and could artificially increase classification accuracies by as much as 27%. This detailed investigation into the proper application of ML techniques for CVD classification can lead to improved data set acquisition required for the SERS community, such that ML on labeled and robust SERS data sets can be practically applied for future point-of-care testing in patients.

SERS-Based Biosensors Combined with Machine Learning for Medical Application

Machine learning-augmented surface-enhanced spectroscopy toward next-generation molecular diagnostics

Innovative Applications and Perspectives of Surface‐Enhanced Raman Spectroscopy Technology in Biomedicine

How Surface-Enhanced Raman Spectroscopy Could Contribute to Medical Diagnoses

Recent Research Progress of Surface-Enhanced Raman Scattering Dominated Analysis Strategies in Early Diagnosis of Diseases

Recent Trends in SERS-Based Plasmonic Sensors for Disease Diagnostics, Biomolecules Detection, and Machine Learning Techniques

Recent research progress of surface enhanced Raman scattering dominated analysis strategy in early diagnosis of diseases.

Surface-Enhanced Raman Spectroscopy-Based Detection of Micro-RNA Biomarkers for Biomedical Diagnosis Using a Comparative Study of Interpretable Machine Learning Algorithms

Application of SERS Techniques in Diagnosis and Bioassay

Toward Sensitive and Reliable Surface-Enhanced Raman Scattering Imaging: from Rational Design to Biomedical Applications.

Machine Learning Using Convolutional Neural Networks for SERS Analysis of Biomarkers in Medical Diagnostics

Discrimination of Genetic Biomarkers of Disease through Machine-Learning-Based Hypothesis Testing of Direct SERS Spectra of DNA and RNA

Label‐free surface‐enhanced Raman spectroscopy coupled with machine learning algorithms in pathogenic microbial identification: Current trends, challenges, and perspectives

Using Machine Learning and Silver Nanoparticle-Based Surface-Enhanced Raman Spectroscopy for Classification of Cardiovascular Disease Biomarkers

Application of SERS in In‐Vitro Biomedical Detection

SERS Tags for Biomedical Detection and Bioimaging

Medical Applications of Surface-Enhanced Raman Scattering.

Advancing Biosensors with Machine Learning

Recent development of surface-enhanced Raman scattering for biosensing

Design and Synthesis of SERS Materials for In Vivo Molecular Imaging and Biosensing

Surface-enhanced Raman Scattering (SERS) Nanoparticles for Biodiagnostics, Bioimaging, and Spectroscopy-Guided Cancer Surgery